The major predictors of response appear to be cancer stage and health of the patient’s immune system. For patients with significant prior therapy, the success rate is lower. For patients with no prior chemotherapy or radiation, the success rate is higher. For more information on efficacy, see “Results Summary.”
It is required that patients discontinue chemotherapy and radiation while undergoing OncoPherese. The immuno-suppressive nature of these treatments can interfere with the efficacy of OncoPherese.
We’re open from 9:00 a.m. to 5:00 p.m. Central European Time (Eastern Standard Time + 6 hours).
From within Germany: +49-8051-909-300
From EU to Germany: +49-8051-909-300
From the U.S.: 011-49-8051-909-300
From within Germany: +49-8051-909-301
From EU to Germany: +49-8051-909-301
From the U.S.: 011-49-8051-909-301